BD launches next-gen needle-free blood draw tech
BD (NYSE: BDX) announced today that it launched next-generation FDA-cleared needle-free blood draw technology.
Stay updated with breaking news from Eric Borin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BD (NYSE: BDX) announced today that it launched next-generation FDA-cleared needle-free blood draw technology.
FRANKLIN LAKES, N.J. - BD , a leading global medical technology company, announced that Laura Boros has been named president of Pharmaceutical Systems , effective today. Boros... | June 1, 2023
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced expanded customer availability of an...
BD announced today that it launched a new ultrasound device to help clinicians achieve optimal IV placement.
BD Effivax™ glass prefillable syringe features enhanced technology to support customers’ manufacturing needs.